
THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL
Publication
, Conference
Wang, A; Lakdawala, NK; Abraham, TP; Nilles, EK; Wojdyla, DM; Owens, AT; Bach, RG; Saberi, S; Sehnert, A; Cresci, S
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
2023
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
2023
Volume
81
Issue
8
Start / End Page
327 / 327
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wang, A., Lakdawala, N. K., Abraham, T. P., Nilles, E. K., Wojdyla, D. M., Owens, A. T., … Cresci, S. (2023). THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 81, pp. 327–327).
Wang, Andrew, Neal K. Lakdawala, Theodore P. Abraham, Ester Kim Nilles, Daniel M. Wojdyla, Anjali Tiku Owens, Richard G. Bach, Sara Saberi, Amy Sehnert, and Sharon Cresci. “THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 81:327–327, 2023.
Wang A, Lakdawala NK, Abraham TP, Nilles EK, Wojdyla DM, Owens AT, et al. THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023. p. 327–327.
Wang, Andrew, et al. “THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 81, no. 8, 2023, pp. 327–327.
Wang A, Lakdawala NK, Abraham TP, Nilles EK, Wojdyla DM, Owens AT, Bach RG, Saberi S, Sehnert A, Cresci S. THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2023. p. 327–327.

Published In
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
EISSN
1558-3597
ISSN
0735-1097
Publication Date
2023
Volume
81
Issue
8
Start / End Page
327 / 327
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology